

CERo Therapeutics Holdings Inc (NASDAQ:CERO) shares are trading higher Tuesday after the company received U.S. Food and Drug Administration (FDA) Orphan Drug...
You can purchase shares of CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc. (OTCQB:CERO) through any online brokerage.
There are no as such competitors for CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc..
There is no analysis for CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc. to provide a consensus price target.
The stock price for CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc. (OTCQB: CERO) is $0.0034 last updated November 6, 2026 at 3:49 PM EST.
There are no upcoming dividends for CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc..
CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc..
CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.
CERo Therapeutics Holdings Inc is an immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain...